Miyazawa et al.
223
Table 6. TLC and HPLC separations of the 2,2,2-trifluoroethyl esters (1) and methyl esters
(2, R′ = CH3) of N-Z-amino acids.
2,2,2-Trifluoroethyl ester
Methyl ester
Ra
TLC, Rfb
HPLC, tR (min)c
TLC, Rfb
HPLC, tR (min)c
CH3
C2H5
0.33
0.38
0.47
0.50
0.54
0.52
0.45
2.39
2.69
3.21
4.42
5.39
5.59
2.92
0.22
0.29
0.35
0.38
0.40
0.41
0.31
2.99
3.50
4.32
5.78
7.86
11.37
3.86
n-C3H7
n-C4H9
n-C5H11
n-C6H13
CH2=CHCH2
aThe side chain of an amino acid [–NHCH(R)CO–].
bSolvent: hexane–diethyl ether (2:1, v/v).
cHPLC conditions: column, Cosmosil 5C18 (4.6 mm i.d. × 150 mm); eluent, 75% aq. MeOH; flow
rate, 1.0 mL min–1; column temperature, 30 °C; detection, UV at 254 nm.
The ee value for each compound compiled in Table 4 is that
obtained by the HPLC procedure utilizing the diastereomeric
separation.
The TLC and HPLC separations of the 2,2,2-trifluoroethyl
esters (1) and methyl esters (2, R′ = CH3) of N-Z-amino ac-
ids carrying aliphatic side chains are shown in Table 6.
Reactions
General procedure for the lipase-catalyzed
transesterification
In a typical experiment, a solution of the 2,2,2-
trifluoroethyl ester of a racemic N-Z-DL-amino acid (DL-1;
0.4 mmol) and an alcohol (1.2 mmol) in an anhydrous or-
ganic solvent (0.8 mL) was stirred with a lipase preparation
(120 mg) at 25 °C. The progress of the reaction was moni-
tored by reversed-phase HPLC on a Cosmosil 5C18 column
(4.6 mm i.d. × 150 mm; Nacalai Tesque, Japan) using aq.
methanol as an eluent. When the desired degree of conver-
sion (~40 % based on the racemic starting ester) had been
achieved, the enzyme was filtered off and washed with di-
ethyl ether. The error of conversion determined by the HPLC
method was estimated as ~ 1%. The filtrate and washing
were combined and concentrated to a small volume, and the
newly formed ester (2) was separated from the unchanged
starting ester (1) by preparative TLC using hexane–diethyl
ether (mainly 2:1, v/v) as a developing solvent. After the ab-
sence of the contaminant starting ester (1) had been con-
firmed by reversed-phase HPLC, the ester formed (2) was
saponified by 0.1 mol/L NaOH in methanol as usual. The ee
value of the resolved N-Z-amino acids (Z-AA) was deter-
mined by the following HPLC procedure (18): the obtained
Z-AA was coupled with Gly-L-Phe-OMe to afford the
diastereomeric tripeptide Z-AA-Gly-L-Phe-OMe, which was
separated by reversed-phase HPLC. The peak area of each
diastereomer separated was measured to calculate the ee
value of the resolved amino acid. When the amino acid AA
bears an aromatic ring, Z-AA was converted to Z-AA-Sar-L-
Phe-OMe (Sar = sarcosine or N-methylglycine) for a better
diastereomeric separation. The kinetic resolution during the
couplings was found to be negligible, probably because
achiral Gly or Sar occupies the coupling site in the amino
component. When the product of the transesterification was
the methyl ester, another procedure was also employed. The
enantiomers of the methyl ester product were separated di-
rectly by normal-phase HPLC on a chiral column, Chiralcel
OD (4.6 mm i.d. × 250 mm; Daicel Chemical Industry,
Japan), using hexane–2-propanol as an eluent (15). The ee
values obtained by these different procedures were consis-
tent with each other within the experimental error ( 2%).
Gram-scale resolution of N-Z-norvaline
The 2,2,2-trifluoroethyl ester of racemic N-Z-DL-norvaline
(DL-1c; 1.40 g, 4.2 mmol) was dissolved in diisopropyl ether
(8 mL), followed by the addition of methanol (520 µL,
12.8 mmol) and then B. cepacia lipase (1.2 g). The reaction
mixture was stirred at 25 °C. The reaction was stopped after
9 h (33% conversion) by removing the enzyme powder by
filtration. The enzyme was washed with diethyl ether. Evap-
oration of the solvent in vacuo from the combined filtrate
and the washing afforded a pale yellow oil, from which the
product (2c) was isolated by column chromatography on sil-
ica gel (Wakogel C-300) using hexane–diethyl ether (10:1,
v/v) as an eluent. Thus, the unreacted trifluoroethyl ester
(1c) eluted first, and further elution afforded the methyl ester
(2c) as a colorless oil. The latter was saponified by
0.1 mol/L NaOH, and the raw material was recrystallized
from EtOAc–petroleum ether to give N-Z-L-norvaline as
colorless crystals: 290 mg (27% yield); mp 87–88.5 °C; [α]D25
–4.2° (c 1.0, acetone). N-Z-L-norvaline thus obtained was re-
esterified with diazomethane, and the resulting methyl ester
was analyzed by HPLC on a Chiralcel OD column: 92% ee.
In another run, the reaction was stopped after 35 h (55%
conversion), and the unreacted trifluoroethyl ester (1c) was
separated from the newly formed methyl ester (2c) by col-
umn chromatography in the same manner as mentioned ear-
lier. The trifluoroethyl ester (1c) thus obtained was saponified
by 0.1 mol/L NaOH, and the raw material was recrystallized
from EtOAc–petroleum ether to give N-Z-D-norvaline as col-
orless crystals: 410 mg (39% yield); mp 89.5–90 °C; [α]D25
+4.6° (c 1.0, acetone); 97% ee by HPLC. 1H NMR
(300 MHz, CDCl3) δ: 0.94 (3H, t. J = 7.4 Hz, CH3), 1.30–
1.50 (2H, m, CH2CH3), 1.61–1.95 (2H, m, CHCH2), 4.41
(1H, q-like, CH), 5.12 (2H, apparent s, PhCH2), 5.27 (1H, d,
J = 8.1 Hz, NH), 7.26–7.41 (5H, m, Ph), 10.48 (1H, br, OH).
Anal. calcd. for C13H17NO4: C, 62.14; H, 6.82; N, 5.57%.
Found: C, 62.30; H, 6.89; N, 5.58%.
© 2008 NRC Canada